Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gaughan

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Pageof 14